[Nature Sub-Journal] A breakthrough discovery: it has been ignored for decades, it can increase the survival rate of patients with bowel cancer
Time of Update: 2021-04-18
bowel cancer patients so that they can receive the most effective treatment. The research was published in the journal Nature Metabolism, entitled "Respiratory complex and tissue lineage drive recurrent mutations
JAMA: The effect of celecoxib combined with FOLFOX standard adjuvant chemotherapy on the disease-free survival rate of colon cancer patients
Time of Update: 2021-04-17
Recently, researchers investigated the effect of adding celecoxib to the adjuvant chemotherapy regimen of fluorouracil, calcium leucovorin and oxaliplatin (FOLFOX) on the disease-free survival rate of patients with stage III colon cancer .
New discovery subverts a century-old model of cancer metabolism
Time of Update: 2021-04-16
restriction, but by specific cell signaling pathways. This is in contrast to the previous popular view that in the tumor microenvironment, cancer cells undergo metabolism to compete to "win" nutrients and inhibit the growth of immune
Trends in Endocrinology & Metabolism: "Starve" cancer cells, the approach and challenge of amino acid depletion therapy
Time of Update: 2021-04-16
Recently, researchers from the Princess Marsima Pediatric Cancer Center of the Netherlands published a review article titled Amino Acid Depletion Therapies: Starving Cancer Cells to Death in the sub-Journal of Cell, Trends in Endocrinology & Metabolism (IF: 11.
the survival rate of patients with locally advanced pancreatic cancer!
Time of Update: 2021-04-13
: according to plan (PP), minor deviation (MiD) or major deviation (MaD). >>
-
-
-
-
Br J Cancer: A few cups of coffee or tea a day can improve the survival rate of breast cancer patients
Time of Update: 2021-03-30
The results showed that increased coffee intake after diagnosis was associated with a decrease in breast cancer-specific mortality: compared to non-drinkers, drinking more than 3 cups of coffee a day corresponds to a 25% reduction in the risk of death.
The accuracy rate is nearly 90%, and Harvard's new AI system successfully assists in the diagnosis of skin cancer earlier
Time of Update: 2021-03-27
The new system successfully distinguished SPL from the non-suspicious lesions in the patient's skin photos, and included an "ugly duckling" standard for the first time, making its evaluation results 88% consistent with the consensus of the three dermatologists.
Br J Cancer: A few cups of coffee or tea a day can improve the survival rate of breast cancer patients
Time of Update: 2021-03-26
The results showed that increased coffee intake after diagnosis was associated with a decrease in breast cancer-specific mortality: compared to non-drinkers, drinking more than 3 cups of coffee a day corresponds to a 25% reduction in the risk of death.
[Nature Sub-Journal] After this treatment of pancreatic cancer mice, the survival rate
Time of Update: 2021-03-22
organs is also reduced. Compared with chemotherapy alone, this may be a powerful treatment strategy for aggressive pancreatic cancer.
-
-
-
-
-
-
-
-
-
-
Libtayo improves the survival rate of cervical cancer patients!
Time of Update: 2021-03-21
According to the recommendation of the Independent Data Monitoring Committee (IDMC), the phase III clinical trial of Libtayo (cemiplimab) for the treatment of patients with recurrent/metastatic cervical cancer who had previously received chemotherapy will be discontinued early.
Eur Radiol: The influence of CT slice thickness in radiomics model in predicting survival rate of non-small cell lung cancer
Time of Update: 2021-03-19
CT layer thickness has no significant impact on the performance of the radiomic model for predicting DFS in patients with non-small cell lung cancer.
Turning Point/Redding repotrectinib Total remission rate of lung cancer treatment is 93%
Time of Update: 2021-03-12
of repotrectinib. A total of 15 patients were included in phase 2 of the study, and preliminary efficacy analysis showed that the objective remission rate (ORR) confirmed by the doctor's assessment was 93% (95% CI:68-100); The updated data
Nat Metabol: Scientists hope to develop a new potential treatment for malignant non-small cell lung cancer
Time of Update: 2021-03-06
January 11, 2021 // -- In a recent study published in the international journal Nature Metabolism, scientists from the University of Texas Southwestern Medical Center and other institutions discovered a new metabolism in a highly invasive form
The treatment of non-small cell lung cancer energizer KRAS inhibitors reached 80.6% disease control rate
Time of Update: 2021-03-03
Today, Amgen announced the latest results from a critical Phase 2 clinical trial in patients with advanced non-small cell lung cancer (NSCLC) who studied the KRAS G12C inhibitor sotorasib (AMG 510).
Cell Metabol: Heavy! Scientists have discovered new paths that promise to attack cancer cells
Time of Update: 2021-02-28
are always looking for ways to remove cancer cells and minimize damage to other parts of the body, one possibility being to identify and target cancer cell-specific processes that, if interfered with, kill only cancer cells. process is very special
Br J Cancer: Analysis of survival rates in breast cancer patients with BRCA2 mutations
Time of Update: 2021-02-26
previous studies have shown that most breast cancers associated with BRCA2 mutations show ER-positive, while ER-positive is a favorable prognostic factor compared to ER-negative in the general early-stage patient population.
AstraZeneia's Imfinzi failed to improve the overall survival rate of patients with head and neck cancer
Time of Update: 2021-02-24
In the second trial, AstraZeneca's Imfinzi failed to improve the overall survival of patients with relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) (OS). update to Imfinzi's KESTREL PHASE III clinical trial found
The disease control rate of 90% mRNA cancer vaccine/Keytruda combination had positive early clinical results
Time of Update: 2021-02-24
mRNA-4157 was used in a phase 1 clinical trial to treat HPV-negative head and neck squamous cell carcinoma (HNSCC) patients with a total remission rate (ORR) of 50% (ORR) and a 9.8-month medium progressive survival (mPFS).
New cancer drugs! The new anti-metabolic compound Lonsurf of Schweija/Dapeng Pharmaceuticals
Time of Update: 2021-02-17
Servier and Taiho Pharmaceutical recently jointly announced that they are evaluating the safety and efficacy of gastric excision groups in TAGS, a global Phase III clinical study of patients treated with metastatic gastric cancer (mGC
